Report Detail
Global (United States, European Union and China) Bacterial Conjunctivitis Drugs Market Research Report 2019-2025
- RnM3682756 |
- 19 August, 2019 |
- Global |
- 118 Pages |
- QYResearch |
- Pharma & Healthcare
Conjunctivitis is an inflammation of the conjunctiva - the clear membrane that covers the outermost layer of an eye and the inner surface of eyelids. Conjunctivitis is segmented into three major categories: infective (viral and bacterial), allergic, and irritant (chemical). Bacterial conjunctivitis is one of the most commonly observed eye problems across all age groups, generally caused by bacteria such as Staphylococcus aureus, Moraxella lacunata, Haemophilus influenza, and others (e.g. Chlamydia trachomatis, Proteus mirabilis, etc.).
The development of multi-drug resistant variants, which is resulting in the augmented use of drugs, is expected to boost market growth during the forecast period. Microbes such as Streptococcus or Staphylococcus are responsible for bacterial conjunctivitis. These microbes change themselves chemically to develop resistance to the drugs. Since this resistance develops due to the irrational use of antibiotics, it may lead to severe complications in the body of the patients. Patients are thus expected to take up more medications such as corticosteroids and higher doses of antibiotics for the treatment of such diseases. This augmented use of drugs like corticosteroids and antibiotics for the treatment of bacterial conjunctivitis will propel the prospects for growth in this market.
The growing genericization of antibacterial drugs has impacted the demand for branded drugs significantly. The generic versions of patented formulations, with almost same efficiency as the latter, are easily available at much lower rates in the market. This has increased the sales volume, albeit at the cost of revenues. Many branded ophthalmic drug manufacturers have incurred huge losses due to the generic cannibalization in this market.
The rising prevalence of multi-drug resistant organisms (MDROs), triggered by wide usage of antibiotics, incorrect drug dosage, and inappropriate medications, has created serious challenges for the treatment of infections such as bacterial conjunctivitis. Researchers across the world are working on discovering efficient drugs for these MDROs. However, the non-availability of effective medications in near future is likely to hamper the market’s growth over the coming years.
In 2019, the market size of Bacterial Conjunctivitis Drugs is 430 million US$ and it will reach 320 million US$ in 2025, growing at a CAGR of -3.7% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Bacterial Conjunctivitis Drugs.
This report studies the global market size of Bacterial Conjunctivitis Drugs, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Bacterial Conjunctivitis Drugs sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Santen Pharmaceutical
Perrigo
Merck
Bayer
Akorn
...
Market Segment by Product Type
Fluoroquinolones
Aminoglycosides
Macrolides
Others
Market Segment by Application
Infective (Viral and Bacterial)
Allergic
Irritant (Chemical)
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Bacterial Conjunctivitis Drugs status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Bacterial Conjunctivitis Drugs manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Bacterial Conjunctivitis Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Bacterial Conjunctivitis Drugs Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Fluoroquinolones
- 1.3.3 Aminoglycosides
- 1.3.4 Macrolides
- 1.3.5 Others
- 1.4 Market Segment by Application
- 1.4.1 Global Bacterial Conjunctivitis Drugs Market Share by Application (2019-2025)
- 1.4.2 Infective (Viral and Bacterial)
- 1.4.3 Allergic
- 1.4.4 Irritant (Chemical)
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Bacterial Conjunctivitis Drugs Market Size
- 2.1.1 Global Bacterial Conjunctivitis Drugs Revenue 2014-2025
- 2.1.2 Global Bacterial Conjunctivitis Drugs Sales 2014-2025
- 2.2 Bacterial Conjunctivitis Drugs Growth Rate by Regions
- 2.2.1 Global Bacterial Conjunctivitis Drugs Sales by Regions 2014-2019
- 2.2.2 Global Bacterial Conjunctivitis Drugs Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Bacterial Conjunctivitis Drugs Sales by Manufacturers
- 3.1.1 Bacterial Conjunctivitis Drugs Sales by Manufacturers 2014-2019
- 3.1.2 Bacterial Conjunctivitis Drugs Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Bacterial Conjunctivitis Drugs Revenue by Manufacturers (2014-2019)
- 3.2.2 Bacterial Conjunctivitis Drugs Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Bacterial Conjunctivitis Drugs Market Concentration Ratio (CR5 and HHI)
- 3.3 Bacterial Conjunctivitis Drugs Price by Manufacturers
- 3.4 Key Manufacturers Bacterial Conjunctivitis Drugs Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Bacterial Conjunctivitis Drugs Market
- 3.6 Key Manufacturers Bacterial Conjunctivitis Drugs Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Fluoroquinolones Sales and Revenue (2014-2019)
- 4.1.2 Aminoglycosides Sales and Revenue (2014-2019)
- 4.1.3 Macrolides Sales and Revenue (2014-2019)
- 4.1.4 Others Sales and Revenue (2014-2019)
- 4.2 Global Bacterial Conjunctivitis Drugs Sales Market Share by Type
- 4.3 Global Bacterial Conjunctivitis Drugs Revenue Market Share by Type
- 4.4 Bacterial Conjunctivitis Drugs Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Bacterial Conjunctivitis Drugs Sales by Application
6 United States
- 6.1 United States Bacterial Conjunctivitis Drugs Breakdown Data by Company
- 6.2 United States Bacterial Conjunctivitis Drugs Breakdown Data by Type
- 6.3 United States Bacterial Conjunctivitis Drugs Breakdown Data by Application
7 European Union
- 7.1 European Union Bacterial Conjunctivitis Drugs Breakdown Data by Company
- 7.2 European Union Bacterial Conjunctivitis Drugs Breakdown Data by Type
- 7.3 European Union Bacterial Conjunctivitis Drugs Breakdown Data by Application
8 China
- 8.1 China Bacterial Conjunctivitis Drugs Breakdown Data by Company
- 8.2 China Bacterial Conjunctivitis Drugs Breakdown Data by Type
- 8.3 China Bacterial Conjunctivitis Drugs Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Bacterial Conjunctivitis Drugs Breakdown Data by Company
- 9.2 Rest of World Bacterial Conjunctivitis Drugs Breakdown Data by Type
- 9.3 Rest of World Bacterial Conjunctivitis Drugs Breakdown Data by Application
- 9.4 Rest of World Bacterial Conjunctivitis Drugs Breakdown Data by Countries
- 9.4.1 Rest of World Bacterial Conjunctivitis Drugs Sales by Countries
- 9.4.2 Rest of World Bacterial Conjunctivitis Drugs Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Santen Pharmaceutical
- 10.1.1 Santen Pharmaceutical Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Bacterial Conjunctivitis Drugs
- 10.1.4 Bacterial Conjunctivitis Drugs Product Introduction
- 10.1.5 Santen Pharmaceutical Recent Development
- 10.2 Perrigo
- 10.2.1 Perrigo Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Bacterial Conjunctivitis Drugs
- 10.2.4 Bacterial Conjunctivitis Drugs Product Introduction
- 10.2.5 Perrigo Recent Development
- 10.3 Merck
- 10.3.1 Merck Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Bacterial Conjunctivitis Drugs
- 10.3.4 Bacterial Conjunctivitis Drugs Product Introduction
- 10.3.5 Merck Recent Development
- 10.4 Bayer
- 10.4.1 Bayer Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Bacterial Conjunctivitis Drugs
- 10.4.4 Bacterial Conjunctivitis Drugs Product Introduction
- 10.4.5 Bayer Recent Development
- 10.5 Akorn
- 10.5.1 Akorn Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Bacterial Conjunctivitis Drugs
- 10.5.4 Bacterial Conjunctivitis Drugs Product Introduction
- 10.5.5 Akorn Recent Development
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Bacterial Conjunctivitis Drugs Sales Channels
- 11.2.2 Bacterial Conjunctivitis Drugs Distributors
- 11.3 Bacterial Conjunctivitis Drugs Customers
12 Market Forecast
- 12.1 Global Bacterial Conjunctivitis Drugs Sales and Revenue Forecast 2019-2025
- 12.2 Global Bacterial Conjunctivitis Drugs Sales Forecast by Type
- 12.3 Global Bacterial Conjunctivitis Drugs Sales Forecast by Application
- 12.4 Bacterial Conjunctivitis Drugs Forecast by Regions
- 12.4.1 Global Bacterial Conjunctivitis Drugs Sales Forecast by Regions 2019-2025
- 12.4.2 Global Bacterial Conjunctivitis Drugs Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Bacterial Conjunctivitis Drugs. Industry analysis & Market Report on Bacterial Conjunctivitis Drugs is a syndicated market report, published as Global (United States, European Union and China) Bacterial Conjunctivitis Drugs Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Bacterial Conjunctivitis Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
